Long-Term Outcomes of Radiotherapy for Pituitary Adenomas

International Journal of Radiation Oncology Biology Physics

Volumn 71, Issue 4, 2008, Pages 994-998

  Snead, Felicia E ^a   Amdur, Robert J ^a   Morris, Christopher G ^a   Mendenhall, William M ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Outcomes; Pituitary adenomas; Radiation therapy

Indexed keywords

ELECTROTHERAPEUTICS; KETONES; PATIENT TREATMENT; PIGMENTS; RADIOTHERAPY; SURGERY; TIMING DEVICES; TUMORS;

CAUSE SPECIFIC SURVIVAL; ELSEVIER (CO); FRACTIONATED RADIOTHERAPY; LOCAL CONTROL (LC); OVERALL SURVIVAL (OS) RATES; PITUITARY ADENOMAS; POST TREATMENTS; VISION LOSS;

TISSUE;

ARTICLE; BRAIN HEMORRHAGE; CANCER GROWTH; CANCER RADIOTHERAPY; CEREBROVASCULAR ACCIDENT; FEMALE; FOLLOW UP; GLIOBLASTOMA; HORMONE RELEASE; HUMAN; HYPOPHYSIS ADENOMA; HYPOPITUITARISM; INTERMETHOD COMPARISON; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE CARE; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RETROSPECTIVE STUDY; SALVAGE THERAPY; SEIZURE; STEREOTACTIC PROCEDURE; SURVIVAL TIME; THYROTROPIN SECRETING ADENOMA; TREATMENT OUTCOME; VISUAL IMPAIRMENT;

ADENOMA; ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; FLORIDA; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; NEOPLASM RECURRENCE, LOCAL; PITUITARY NEOPLASMS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 45449084398     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.11.057     Document Type: Article

References (23)

1. Ezzat S., Asa S.L., Couldwell W.T., et al. The prevalence of pituitary adenomas: a systematic review. Cancer 101 (2004) 613-619
2. Surawicz T.S., McCarthy B.J., Kupelian V., et al. Descriptive epidemiology of primary brain and CNS tumors: results from the Central Brain Tumor Registry of the United States, 1990-1994. Neuro Oncol 1 (1999) 14-25
3. Turner H.E., Stratton I.M., Byrne J.V., et al. Audit of selected patients with nonfunctioning pituitary adenomas treated without irradiation-a follow-up study. Clin Endocrinol (Oxf) 51 (1999) 281-284
4. Brada M., Rajan B., Traish D., et al. The long-term efficacy of conservative surgery and radiotherapy in the control of pituitary adenomas. Clin Endocrinol (Oxf) 38 (1993) 571-578
5. Milker-Zabel S., Debus J., Thilmann C., et al. Fractionated stereotactically guided radiotherapy and radiosurgery in the treatment of functional and nonfunctional adenomas of the pituitary gland. Int J Radiat Oncol Biol Phys 50 (2001) 1279-1286
6. Stieber V., and Deguzman A. Pituitary. In: Perez C.A., Brady L.W., Halperin E.C., and Schmidt-Ullrich R.K. (Eds). Principles and practice of radiation oncology (2004), Lippincott, Williams and Wilkins, Philadelphia 839-859
7. Tsang R.W., Brierley J.D., Panzarella T., et al. Radiation therapy for pituitary adenoma: Treatment outcome and prognostic factors. Int J Radiat Oncol Biol Phys 30 (1994) 557-565
8. Brada M., Ashley S., Ford D., et al. Cerebrovascular mortality in patients with pituitary adenoma. Clin Endocrinol (Oxf) 57 (2002) 713-717
9. Rush S., and Cooper P.R. Symptom resolution, tumor control, and side effects following postoperative radiotherapy for pituitary macroadenomas. Int J Radiat Oncol Biol Phys 37 (1997) 1031-1034
10. Minniti G., Traish D., Ashley S., et al. Fractionated stereotactic radiotherapy for secreting and nonsecreting pituitary adenomas. Clin Endocrinol (Oxford) 64 (2006) 542-548
11. Kaplan E.L., and Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 457-481
12. Cox D.R. Regression models and life tables-Series B (Methodological). J R Stat Soc 34 (1972) 187-220
13. Ciric I., Mikhael M., Stafford T., et al. Transsphenoidal microsurgery of pituitary macroadenomas with long-term follow-up results. J Neurosurg 59 (1983) 395-401
14. Gittoes N.J., Bates A.S., Tse W., et al. Radiotherapy for non-function pituitary tumours. Clin Endocrinol (Oxf) 48 (1998) 331-337
15. Greenman Y., Ouaknine G., Veshchev I., et al. Postoperative surveillance of clinically nonfunctioning pituitary macroadenomas: Markers of tumour quiescence and regrowth. Clin Endocrinol (Oxf) 58 (2003) 763-769
16. Grigsby P.W., Simpson J.R., and Fineberg B. Late regrowth of pituitary adenomas after irradiation and/or surgery. Hazard function analysis. Cancer 63 (1989) 1308-1312
17. Flickinger J.C., Nelson P.B., Martinez A.J., et al. Radiotherapy of nonfunctional adenomas of the pituitary gland. Results with long-term follow-up. Cancer 63 (1989) 2409-2414
18. Sasaki R., Murakami M., Okamoto Y., et al. The efficacy of conventional radiation therapy in the management of pituitary adenoma. Int J Radiat Oncol Biol Phys 47 (2000) 1337-1345
19. Dekkers O.M., van der Klaauw A.A., Pereira A.M., et al. Quality of life is decreased after treatment for nonfunctioning pituitary macroadenoma. J Clin Endocrinol Metab 91 (2006) 3364-3369
20. McCord M.W., Buatti J.M., Fennell E.M., et al. Radiotherapy for pituitary adenoma: Long-term outcome and sequelae. Int J Radiat Oncol Biol Phys 39 (1997) 437-444
21. Erfurth E.M., Bulow B., Svahn-Tapper G., et al. Risk factors for cerebrovascular deaths in patients operated and irradiated for pituitary tumors. J Clin Endocrinol Metab 87 (2002) 4892-4899
22. Fisher B.J., Gaspar L.E., and Noone B. Radiation therapy of pituitary adenoma: Delayed sequelae. Radiology 187 (1993) 843-846
23. Minniti G., Traish D., Ashley S., et al. Risk of second brain tumor after conservative surgery and radiotherapy for pituitary adenoma: Update after an additional 10 years. J Clin Endocrinol Metab 90 (2005) 800-804